View Financial HealthBlueRiver Acquisition 配当と自社株買い配当金 基準チェック /06BlueRiver Acquisition配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jul 08BlueRiver Acquisition Corp., Annual General Meeting, Jul 21, 2025BlueRiver Acquisition Corp., Annual General Meeting, Jul 21, 2025. Location: goodwin procter llp, 620 eighth avenue, new york United Statesお知らせ • Apr 02BlueRiver Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2025, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 11/14/2024, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 15BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 08/14/2024, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 19The Staff of NYSE Regulation Determines to Suspend Trading in the Class A Ordinary Shares and Units of BlueRiver AcquisitionOn July 15, 2024, NYSE American LLC announced that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares and units of BlueRiver Acquisition Corp. from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities, which included Company’s Class A ordinary shares, units and redeemable warrants (collectively, “Securities”), and the Company appealed such delisting determination. On July 12, 2024, the Company withdrew its appeal. On July 3, 2024, the NYSE American suspended trading in the Company’s redeemable warrants as they were trading at an abnormally low selling price. On July 15, 2024, the NYSE American suspended trading in the Company’s Class A ordinary shares and units and delisted the Company’s Securities by filing a Form 25 with the Securities and Exchange Commission. The Company may submit an application to have its Securities quoted on the OTCQX Marketplace (“OTCQX”). The Company cannot provide any assurance that the Securities will commence or continue to trade on this market, whether broker-dealers will continue to provide public quotes of the Securities on this market, whether the trading volume of the Securities will be sufficient to provide for an efficient trading market or whether quotes for the Securities will continue on this market in the future.お知らせ • Jul 08BlueRiver Acquisition Receives a Written Notice from NYSE AmericanOn July 3, 2024, BlueRiver Acquisition Corp. received a written notice from NYSE American LLC indicating that the staff of NYSE Regulation has determined to suspend trading in the redeemable warrants of the Company (BLUA WS) from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities and will now suspend trading in the redeemable warrants as they are trading at an abnormally low price. Trading in the Company’s Class A ordinary shares (BLUA) and units (BLUA.U) will continue to trade on the NYSE American during the pendency of the Company’s appeal rights.お知らせ • Feb 08BlueRiver Acquisition Receives Commencement of Delisting Notice from the NYSE American LLCOn February 2, 2024, BlueRiver Acquisition Corp. (‘BlueRiver’ or the ‘Company’) received a letter from the NYSE American LLC (‘NYSE American’ or the ‘Exchange’) stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Class A ordinary shares, Units and Rights (collectively, the ‘Securities’) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company specified in its registration statement. At this time, the Securities have not been suspended and will continue to trade. As indicated in the letter from NYSE American, the Company has a right to a review of the delisting determination by a Committee of the Board of Directors of the Exchange, provided a written request for such review is requested no later than February 9, 2024. The Company intends to make such request.お知らせ • Jan 18BlueRiver Acquisition Corp., Annual General Meeting, Feb 01, 2024BlueRiver Acquisition Corp., Annual General Meeting, Feb 01, 2024, at 09:00 US Eastern Standard Time.Board Change • Jan 07Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Alok Sama was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Aug 16High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Co-Chairman & Co-CEO John Gregg is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jul 25Spinal Stabilization Technologies, LLC (“SST”) entered into a definitive business combination agreement to acquire BlueRiver Acquisition Corp. (NYSEAM:BLUA) from BlueRiver Ventures, LLC and others for approximately $260 million in a reverse merger transaction.Spinal Stabilization Technologies, LLC (“SST”) entered into a definitive business combination agreement to acquire BlueRiver Acquisition Corp. (NYSEAM:BLUA) from BlueRiver Ventures, LLC and others for approximately $260 million in a reverse merger transaction on July 21, 2023. Upon the closing of the proposed transaction between SST and BlueRiver, the combined company will operate as Spinal Stabilization Technologies and be listed on an approved stock exchange. SST shareholders will roll 100% of their existing SST equity holdings and are expected to own equity-linked securities representing approximately 70% of combined company on a non-fully diluted basis immediately following the closing of the proposed business combination, assuming 100% redemptions by BlueRiver’s public stockholders and a proposed future $40.0 million PIPE raise. Board of direcotrs of resulting issuer will consist of: Joe de Compiegne, Randall Mays, Vic Bertrand, Mark Novotny, and Dr. Phillips. The transaction is subject to expiration of the waiting period under the HSR Act; regulatory approvals; the Class A common stock of Surviving company contemplated to be listed pursuant to the Merger agreement shall have been listed on an approved stock exchange; the requisite approval of the BlueRiver shareholders shall have been obtained; the requisite approval of the members of SST shall have been obtained; the registration statement on Form S-4 shall have become effective; BlueRiver shall have at least $5,000,001 of net tangible assets; and the satisfaction of other closing conditions, including the completion of mutual due diligence and a committed PIPE or other mutually satisfactory financing resulting in net proceeds of at least $10 million. BlueRiver’s and SST’s respective boards of directors have approved the transaction. The transaction is expected to close in the fourth quarter of 2023, or early 2024. Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, acts as BlueRiver’s exclusive financial advisor and lead capital markets advisor. Dan Espinoza of Goodwin Procter LLP is acting as BlueRiver’s legal counsel. Kreager Mitchell, PLLC is acting as SST’s legal counsel.お知らせ • May 17BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 05/16/2023, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Board Change • Feb 14High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Co-Chairman & Co-CEO John Gregg is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Nov 15BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 11/14/2022, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 18BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 05/17/2021, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: BLUA.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: BLUA.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場BlueRiver Acquisition 配当利回り対市場BLUA.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (BLUA.F)n/a市場下位25% (US)1.4%市場トップ25% (US)4.3%業界平均 (Capital Markets)2.1%アナリスト予想 (BLUA.F) (最長3年)n/a注目すべき配当: BLUA.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: BLUA.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: BLUA.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: BLUA.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/20 10:27終値2026/04/23 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BlueRiver Acquisition Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 08BlueRiver Acquisition Corp., Annual General Meeting, Jul 21, 2025BlueRiver Acquisition Corp., Annual General Meeting, Jul 21, 2025. Location: goodwin procter llp, 620 eighth avenue, new york United States
お知らせ • Apr 02BlueRiver Acquisition Corp. announced delayed annual 10-K filingOn 04/01/2025, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 11/14/2024, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 15BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 08/14/2024, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 19The Staff of NYSE Regulation Determines to Suspend Trading in the Class A Ordinary Shares and Units of BlueRiver AcquisitionOn July 15, 2024, NYSE American LLC announced that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares and units of BlueRiver Acquisition Corp. from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities, which included Company’s Class A ordinary shares, units and redeemable warrants (collectively, “Securities”), and the Company appealed such delisting determination. On July 12, 2024, the Company withdrew its appeal. On July 3, 2024, the NYSE American suspended trading in the Company’s redeemable warrants as they were trading at an abnormally low selling price. On July 15, 2024, the NYSE American suspended trading in the Company’s Class A ordinary shares and units and delisted the Company’s Securities by filing a Form 25 with the Securities and Exchange Commission. The Company may submit an application to have its Securities quoted on the OTCQX Marketplace (“OTCQX”). The Company cannot provide any assurance that the Securities will commence or continue to trade on this market, whether broker-dealers will continue to provide public quotes of the Securities on this market, whether the trading volume of the Securities will be sufficient to provide for an efficient trading market or whether quotes for the Securities will continue on this market in the future.
お知らせ • Jul 08BlueRiver Acquisition Receives a Written Notice from NYSE AmericanOn July 3, 2024, BlueRiver Acquisition Corp. received a written notice from NYSE American LLC indicating that the staff of NYSE Regulation has determined to suspend trading in the redeemable warrants of the Company (BLUA WS) from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company’s listed securities and will now suspend trading in the redeemable warrants as they are trading at an abnormally low price. Trading in the Company’s Class A ordinary shares (BLUA) and units (BLUA.U) will continue to trade on the NYSE American during the pendency of the Company’s appeal rights.
お知らせ • Feb 08BlueRiver Acquisition Receives Commencement of Delisting Notice from the NYSE American LLCOn February 2, 2024, BlueRiver Acquisition Corp. (‘BlueRiver’ or the ‘Company’) received a letter from the NYSE American LLC (‘NYSE American’ or the ‘Exchange’) stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Class A ordinary shares, Units and Rights (collectively, the ‘Securities’) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company specified in its registration statement. At this time, the Securities have not been suspended and will continue to trade. As indicated in the letter from NYSE American, the Company has a right to a review of the delisting determination by a Committee of the Board of Directors of the Exchange, provided a written request for such review is requested no later than February 9, 2024. The Company intends to make such request.
お知らせ • Jan 18BlueRiver Acquisition Corp., Annual General Meeting, Feb 01, 2024BlueRiver Acquisition Corp., Annual General Meeting, Feb 01, 2024, at 09:00 US Eastern Standard Time.
Board Change • Jan 07Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Alok Sama was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Aug 16High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Co-Chairman & Co-CEO John Gregg is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jul 25Spinal Stabilization Technologies, LLC (“SST”) entered into a definitive business combination agreement to acquire BlueRiver Acquisition Corp. (NYSEAM:BLUA) from BlueRiver Ventures, LLC and others for approximately $260 million in a reverse merger transaction.Spinal Stabilization Technologies, LLC (“SST”) entered into a definitive business combination agreement to acquire BlueRiver Acquisition Corp. (NYSEAM:BLUA) from BlueRiver Ventures, LLC and others for approximately $260 million in a reverse merger transaction on July 21, 2023. Upon the closing of the proposed transaction between SST and BlueRiver, the combined company will operate as Spinal Stabilization Technologies and be listed on an approved stock exchange. SST shareholders will roll 100% of their existing SST equity holdings and are expected to own equity-linked securities representing approximately 70% of combined company on a non-fully diluted basis immediately following the closing of the proposed business combination, assuming 100% redemptions by BlueRiver’s public stockholders and a proposed future $40.0 million PIPE raise. Board of direcotrs of resulting issuer will consist of: Joe de Compiegne, Randall Mays, Vic Bertrand, Mark Novotny, and Dr. Phillips. The transaction is subject to expiration of the waiting period under the HSR Act; regulatory approvals; the Class A common stock of Surviving company contemplated to be listed pursuant to the Merger agreement shall have been listed on an approved stock exchange; the requisite approval of the BlueRiver shareholders shall have been obtained; the requisite approval of the members of SST shall have been obtained; the registration statement on Form S-4 shall have become effective; BlueRiver shall have at least $5,000,001 of net tangible assets; and the satisfaction of other closing conditions, including the completion of mutual due diligence and a committed PIPE or other mutually satisfactory financing resulting in net proceeds of at least $10 million. BlueRiver’s and SST’s respective boards of directors have approved the transaction. The transaction is expected to close in the fourth quarter of 2023, or early 2024. Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, acts as BlueRiver’s exclusive financial advisor and lead capital markets advisor. Dan Espinoza of Goodwin Procter LLP is acting as BlueRiver’s legal counsel. Kreager Mitchell, PLLC is acting as SST’s legal counsel.
お知らせ • May 17BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 05/16/2023, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Board Change • Feb 14High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Co-Chairman & Co-CEO John Gregg is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Nov 15BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 11/14/2022, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 18BlueRiver Acquisition Corp. announced delayed 10-Q filingOn 05/17/2021, BlueRiver Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.